Company: NIVFW
Filing Date: 2025-08-22
Form Type: DRS
Source: 0001213900-25-079717
Chunk: 1

Company: NewGenIvf Group Ltd
Filing Date: 2025-08-22
Form: DRS
Chunk 1
---
pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of
the earlier effective registration statement for the same offering. ☐

Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.

Emerging growth company ☒

If an emerging growth company that prepares its
financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition
period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities
Act. ☐

The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act or until the Registration Statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.

The information in this preliminary prospectus is not complete and may be changed. The selling shareholders named in this preliminary prospectus may not sell these securities until the Registration Statement filed with the Securities and Exchange Commission, of which this preliminary prospectus is a part, is effective. This preliminary prospectus is not an offer to sell these securities and the selling shareholders named in this preliminary prospectus is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.

<div align='center'>PRELIMINARY PROSPECTUS (Subject to Completion)

Dated , 2025.

50,000,000 Class A Ordinary Shares

NewGenIvf Group Limited</div>

This prospectus relates to
the resale by the selling securityholders identified in this prospectus (“Selling Securityholders”) of up to 50,000,000 Class
A Ordinary Shares, no par value per share (“Class A Ordinary Shares”), consisting of (i) 20,000,000 Class A Ordinary Shares
issuable by the Company to White Lion Capital, LLC (“White Lion”) in connection with the Common Stock Purchase Agreement dated
as of November 21, 2024, by and between the Company and White Lion (the “White Lion Purchase Agreement”); and (ii) 30,000,000
Class A Ordinary Shares issuable to JAK Opportunities VI LLC